Home

CHEBI:91091

released
Treatment Term Name
GSK3 inhibition
Treatment Type
chemical
Treatment Summary
Treatment of 4 μM GSK3 inhibition for 7 days
Amount
4 μMs
Duration
7 days
Purpose
antagonist
Submitter Comment
Cells were treated with 4uM CHIR99021 for 1 week before cells were harvested for ATAC-seq and RNA seq
Aliases
charles-gersbach:treatment-CHIR99021-chir-i

Treated Biosamples

6 items
Sample Terms
Summary
InVitroSystem
GM25256 (WTC-11) differentiated cell specimen induced to cardiac muscle cell for 28 days, male, Homo sapiens treated with 4 μM GSK3 inhibition for 7 days
InVitroSystem
GM25256 (WTC-11) differentiated cell specimen induced to cardiac muscle cell for 28 days, male, Homo sapiens treated with 4 μM GSK3 inhibition for 7 days
InVitroSystem
GM25256 (WTC-11) differentiated cell specimen induced to cardiac muscle cell for 28 days, male, Homo sapiens treated with 4 μM GSK3 inhibition for 7 days
InVitroSystem
GM25256 (WTC-11) differentiated cell specimen induced to cardiac muscle cell for 28 days, male, Homo sapiens treated with 4 μM GSK3 inhibition for 7 days
InVitroSystem
GM25256 (WTC-11) differentiated cell specimen induced to cardiac muscle cell for 28 days, male, Homo sapiens treated with 4 μM GSK3 inhibition for 7 days
InVitroSystem
GM25256 (WTC-11) differentiated cell specimen induced to cardiac muscle cell for 28 days, male, Homo sapiens treated with 4 μM GSK3 inhibition for 7 days

Attribution

Award
HG012053
Principal Investigator(s)
Contact P.I.
Charles Gersbach
Lab
Charles Gersbach, Duke